Visit coverage vs medication coverage
The office visit and the medication are often covered under different parts of the plan. A covered weight-loss visit does not automatically mean Zepbound is approved.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking.
Lilly publishes different savings and self-pay paths depending on insurance status. Commercially insured patients and self-pay patients can see very different pricing rules, while government beneficiaries often follow a separate access path. Program terms can change, so the workflow matters more than any one static number copied off the internet.
Zepbound contains tirzepatide and is used with nutrition and activity changes for adult weight management. It is also approved for moderate-to-severe obstructive sleep apnea in adults with obesity. It is not interchangeable with a promise of weight loss, insurance approval, or local stock.
Adults with obesity, or overweight and a weight-related condition, may qualify for weight treatment. OSA treatment requires the specified sleep-apnea diagnosis and obesity. Clinical review considers pregnancy, severe gastrointestinal problems, other medicines, and treatment continuity.
Confirm the indication and the exact pen or vial presentation. Start with the prescriber’s initiation schedule, learn device-specific administration, and plan nutrition, symptoms, monitoring, and refills. Review the visit, drug benefit, prior authorization, and any savings eligibility separately. Self-pay does not remove clinical monitoring needs.
Bring your weight and treatment history, medicines and supplements, relevant glucose, kidney, and lipid results, and the exact product you have used before. Mention previous side effects, eye disease, eating difficulties, and pregnancy plans. If insurance denied treatment, bring the denial and plan details.
Review a personal or family history of medullary thyroid cancer, MEN 2, severe stomach-emptying problems, pancreatitis, gallbladder disease, allergies, and pregnancy plans before treatment. Nausea, vomiting, constipation, or diarrhea can occur. Persistent severe abdominal pain or inability to keep fluids down needs emergency department assessment now. Call 911 for breathing difficulty, a severe allergic reaction, loss of consciousness or unsafe travel. Tell the anesthesia team about treatment before a procedure. Do not combine GLP-1 medicines or change the dose yourself. Use non-oral contraception or add a barrier method for four weeks after starting and each dose increase. Continue prescribed CPAP or other OSA treatment until the sleep clinician reviews whether it can change.
Review weight trend, appetite, food and fluid intake, bowel symptoms, and treatment tolerability. Check glucose and adjust other diabetes medicines with the prescriber when relevant. Agree on how to contact the team between visits and what to do if a refill is delayed. Continued treatment depends on benefit, safety, access, and your goals.
Confirm the exact service, clinician, formulation, appointment, and refill route before booking. The evaluation, tests, medicine, administration, and follow-up may have separate costs and benefits. Ask for current estimates and required records. An FDA-approved drug or a clinic address does not establish pharmacy stock, onsite treatment, coverage, or a prescription. If access changes, contact the treating team before interrupting treatment.
Confirm that the selected Nao clinic and clinician participate in your specific plan for the consultation. Ask about the visit charge, tests and follow-up separately from Zepbound. Lilly’s drug-access programs do not establish the clinic’s payer participation, and an insured visit does not guarantee that the medicine is covered.
A coverage decision can turn on the treatment indication, plan exclusions, prior authorization and the records submitted. Ask the plan for its actual criteria and the specific reason for any denial; do not assume that every plan uses the same barrier. Lilly support or a prescription does not guarantee approval or eliminate ongoing costs.
No. As of October 9, 2026, Lilly’s Zepbound commercial savings-card terms exclude people enrolled in government-funded coverage, including Medicare and Medicaid. Eligibility also depends on the exact presentation, commercial coverage and other current terms. Confirm the offer, activation requirement, maximum benefit and refill limits directly; an advertised amount is not a guarantee of your final cost.
Ask for the plan’s written reason for denial and review it with the prescriber. Missing records, an excluded use or another plan rule can call for different next steps. Discuss an appeal when appropriate, a covered alternative or the current Lilly self-pay route, including affordable refills. Do not start on the assumption that a later appeal will succeed.
It depends on your exact Aetna pharmacy benefit plan, plan year and prescribed indication. Aetna’s public drug search asks for the plan name and year. A member-account search shows personalized coverage and pricing. Check whether Zepbound is covered for weight management or the qualifying sleep-apnea indication, whether an exclusion applies, and what authorization and records are required. Ask about the copay and dispensing pharmacy before filling. An Aetna policy or another member’s approval does not guarantee your benefit.
The office visit and the medication are often covered under different parts of the plan. A covered weight-loss visit does not automatically mean Zepbound is approved.
Approval commonly depends on BMI documentation, weight-related conditions, prior treatment attempts, and whether the employer plan excludes obesity drugs entirely.
Commercial savings programs can exist, but government beneficiaries often follow different access rules and should not assume the same savings path applies.
If insurance slows the start or the benefit excludes Zepbound, the self-pay workflow guide becomes more useful than waiting with no operational plan.
Bronx
932 E 174th St, Bronx, NY 10460
A Bronx access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods.
View weight-loss location Get directions
Queens
37-15 23rd Ave, Astoria, NY 11105
A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods.
View weight-loss location Get directions
Bronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.
View weight-loss location Get directions
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
A Brooklyn access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods.
View weight-loss location Get directions
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities.
View weight-loss location Get directions
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.
View weight-loss location Get directions
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.
View weight-loss location Get directions
Queens
30-07 36th Ave, Astoria, NY 11106
A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.
View weight-loss location Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities.
View weight-loss location Get directions
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods.
View weight-loss location Get directions
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.
View weight-loss location Get directions
Confirm the visit, testing and treatment costs separately with the clinic and your insurer.
Open main Zepbound overview